Skip to content

Effect of compound betamethasone combined with ropivacaine for erector spinae plane block on analgesia and recovery quality after thoracoscopic surgery

Effect of compound betamethasone combined with ropivacaine for erector spinae plane block on analgesia and recovery quality after thoracoscopic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087781
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-05
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Experimental group:Compound betamethasone combined with ropivacaine erector spinae plane block
Control group:Ropivacaine alone erector spinae plane block

Sponsors

Yan'an Hospital of Kunming City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age= 18 years old, gender is not limited; 2. ASA grading I.~III. 3. Patients who are scheduled to undergo elective thoracoscopic unilateral partial lung resection; 4. Those who voluntarily join this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating patients; 2. Those who are allergic to compound betamethasone, ropivacaine or other anesthetic drugs; 3. Patients with severe coagulation disorders and risk of bleeding; 4. Patients receiving chemotherapy and hormone therapy; 5. Patients with a history of spinal surgery, infection or cancer at the puncture site; 6. History of abuse of alcohol, opioids or other psychotropic substances; 7. Patients who cannot cooperate with the study due to language comprehension disorders, hearing impairments, mental illnesses, etc.; 8. Patients who are scheduled to be transferred to the intensive care unit (ICU) before surgery; 9. Patients who have participated in other studies.

Design outcomes

Primary

MeasureTime frame
The incidence of moderate to severe pain in 24 hours after surgery;Postoperative recovery quality;

Secondary

MeasureTime frame
The incidence and severity of nausea and vomiting at 24 and 48 hours after surgery were carried out;

Countries

China

Contacts

Public ContactLiu Linfen

Yan'an Hospital of Kunming

251720884@qq.com+86 137 6917 3912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026